nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP3A7—Simvastatin—atherosclerosis	0.0486	0.0648	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0486	0.0648	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0476	0.0634	CbGbCtD
Ifosfamide—CYP3A7—Lovastatin—atherosclerosis	0.0476	0.0634	CbGbCtD
Ifosfamide—CYP2B6—Simvastatin—atherosclerosis	0.0463	0.0617	CbGbCtD
Ifosfamide—CYP3A5—Rosuvastatin—atherosclerosis	0.0392	0.0523	CbGbCtD
Ifosfamide—CYP3A5—Simvastatin—atherosclerosis	0.0365	0.0486	CbGbCtD
Ifosfamide—CYP3A5—Pravastatin—atherosclerosis	0.0357	0.0476	CbGbCtD
Ifosfamide—CYP3A5—Lovastatin—atherosclerosis	0.0357	0.0476	CbGbCtD
Ifosfamide—CYP2C8—Simvastatin—atherosclerosis	0.0351	0.0467	CbGbCtD
Ifosfamide—CYP2C8—Pravastatin—atherosclerosis	0.0343	0.0457	CbGbCtD
Ifosfamide—CYP2C8—Lovastatin—atherosclerosis	0.0343	0.0457	CbGbCtD
Ifosfamide—CYP2C19—Rosuvastatin—atherosclerosis	0.0316	0.0422	CbGbCtD
Ifosfamide—CYP2C19—Simvastatin—atherosclerosis	0.0294	0.0392	CbGbCtD
Ifosfamide—CYP2C19—Lovastatin—atherosclerosis	0.0288	0.0384	CbGbCtD
Ifosfamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0263	0.0351	CbGbCtD
Ifosfamide—CYP2C9—Simvastatin—atherosclerosis	0.0245	0.0326	CbGbCtD
Ifosfamide—CYP2C9—Lovastatin—atherosclerosis	0.0239	0.0319	CbGbCtD
Ifosfamide—CYP2C9—Pravastatin—atherosclerosis	0.0239	0.0319	CbGbCtD
Ifosfamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0153	0.0204	CbGbCtD
Ifosfamide—CYP3A4—Ezetimibe—atherosclerosis	0.0153	0.0204	CbGbCtD
Ifosfamide—CYP3A4—Simvastatin—atherosclerosis	0.0142	0.0189	CbGbCtD
Ifosfamide—CYP3A4—Pravastatin—atherosclerosis	0.0139	0.0185	CbGbCtD
Ifosfamide—CYP3A4—Lovastatin—atherosclerosis	0.0139	0.0185	CbGbCtD
Ifosfamide—Cough—Rosuvastatin—atherosclerosis	0.00044	0.0025	CcSEcCtD
Ifosfamide—Angiopathy—Ezetimibe—atherosclerosis	0.000437	0.00249	CcSEcCtD
Ifosfamide—Immune system disorder—Ezetimibe—atherosclerosis	0.000435	0.00247	CcSEcCtD
Ifosfamide—Erythema multiforme—Simvastatin—atherosclerosis	0.000434	0.00247	CcSEcCtD
Ifosfamide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000434	0.00247	CcSEcCtD
Ifosfamide—Alopecia—Lovastatin—atherosclerosis	0.000434	0.00247	CcSEcCtD
Ifosfamide—Myalgia—Rosuvastatin—atherosclerosis	0.000429	0.00244	CcSEcCtD
Ifosfamide—Arthralgia—Rosuvastatin—atherosclerosis	0.000429	0.00244	CcSEcCtD
Ifosfamide—Flushing—Simvastatin—atherosclerosis	0.000426	0.00242	CcSEcCtD
Ifosfamide—Alopecia—Ezetimibe—atherosclerosis	0.000425	0.00242	CcSEcCtD
Ifosfamide—Haemoglobin—Niacin—atherosclerosis	0.000424	0.00241	CcSEcCtD
Ifosfamide—Mental disorder—Ezetimibe—atherosclerosis	0.000422	0.0024	CcSEcCtD
Ifosfamide—Haemorrhage—Niacin—atherosclerosis	0.000421	0.0024	CcSEcCtD
Ifosfamide—Hepatitis—Niacin—atherosclerosis	0.000421	0.0024	CcSEcCtD
Ifosfamide—Malnutrition—Ezetimibe—atherosclerosis	0.000419	0.00238	CcSEcCtD
Ifosfamide—Erythema—Ezetimibe—atherosclerosis	0.000419	0.00238	CcSEcCtD
Ifosfamide—Hepatitis—Pravastatin—atherosclerosis	0.000415	0.00236	CcSEcCtD
Ifosfamide—Confusional state—Rosuvastatin—atherosclerosis	0.000415	0.00236	CcSEcCtD
Ifosfamide—Chills—Simvastatin—atherosclerosis	0.000412	0.00234	CcSEcCtD
Ifosfamide—Infection—Rosuvastatin—atherosclerosis	0.000409	0.00233	CcSEcCtD
Ifosfamide—Visual impairment—Niacin—atherosclerosis	0.000406	0.00231	CcSEcCtD
Ifosfamide—Alopecia—Simvastatin—atherosclerosis	0.000406	0.00231	CcSEcCtD
Ifosfamide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000403	0.0023	CcSEcCtD
Ifosfamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000403	0.00229	CcSEcCtD
Ifosfamide—Vision blurred—Lovastatin—atherosclerosis	0.000403	0.00229	CcSEcCtD
Ifosfamide—Mental disorder—Simvastatin—atherosclerosis	0.000402	0.00229	CcSEcCtD
Ifosfamide—Visual impairment—Pravastatin—atherosclerosis	0.0004	0.00228	CcSEcCtD
Ifosfamide—Erythema—Simvastatin—atherosclerosis	0.0004	0.00227	CcSEcCtD
Ifosfamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000396	0.00226	CcSEcCtD
Ifosfamide—Eye disorder—Niacin—atherosclerosis	0.000394	0.00224	CcSEcCtD
Ifosfamide—Tinnitus—Niacin—atherosclerosis	0.000393	0.00224	CcSEcCtD
Ifosfamide—Erythema multiforme—Pravastatin—atherosclerosis	0.000392	0.00223	CcSEcCtD
Ifosfamide—Flushing—Niacin—atherosclerosis	0.000391	0.00223	CcSEcCtD
Ifosfamide—Angioedema—Lovastatin—atherosclerosis	0.00039	0.00222	CcSEcCtD
Ifosfamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000389	0.00221	CcSEcCtD
Ifosfamide—Anaemia—Ezetimibe—atherosclerosis	0.000387	0.0022	CcSEcCtD
Ifosfamide—Tinnitus—Pravastatin—atherosclerosis	0.000387	0.0022	CcSEcCtD
Ifosfamide—Malaise—Lovastatin—atherosclerosis	0.000385	0.00219	CcSEcCtD
Ifosfamide—Flushing—Pravastatin—atherosclerosis	0.000385	0.00219	CcSEcCtD
Ifosfamide—Cardiac disorder—Pravastatin—atherosclerosis	0.000385	0.00219	CcSEcCtD
Ifosfamide—Vertigo—Lovastatin—atherosclerosis	0.000384	0.00218	CcSEcCtD
Ifosfamide—Angioedema—Ezetimibe—atherosclerosis	0.000383	0.00218	CcSEcCtD
Ifosfamide—Angiopathy—Niacin—atherosclerosis	0.000382	0.00218	CcSEcCtD
Ifosfamide—Leukopenia—Lovastatin—atherosclerosis	0.000382	0.00218	CcSEcCtD
Ifosfamide—Chills—Niacin—atherosclerosis	0.000378	0.00215	CcSEcCtD
Ifosfamide—Malaise—Ezetimibe—atherosclerosis	0.000378	0.00215	CcSEcCtD
Ifosfamide—Vision blurred—Simvastatin—atherosclerosis	0.000377	0.00214	CcSEcCtD
Ifosfamide—Arrhythmia—Niacin—atherosclerosis	0.000377	0.00214	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000375	0.00213	CcSEcCtD
Ifosfamide—Alopecia—Niacin—atherosclerosis	0.000372	0.00212	CcSEcCtD
Ifosfamide—Chills—Pravastatin—atherosclerosis	0.000372	0.00212	CcSEcCtD
Ifosfamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000371	0.00211	CcSEcCtD
Ifosfamide—Arrhythmia—Pravastatin—atherosclerosis	0.000371	0.00211	CcSEcCtD
Ifosfamide—Palpitations—Ezetimibe—atherosclerosis	0.00037	0.00211	CcSEcCtD
Ifosfamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000369	0.0021	CcSEcCtD
Ifosfamide—Anaemia—Simvastatin—atherosclerosis	0.000369	0.0021	CcSEcCtD
Ifosfamide—Malnutrition—Niacin—atherosclerosis	0.000367	0.00209	CcSEcCtD
Ifosfamide—Erythema—Niacin—atherosclerosis	0.000367	0.00209	CcSEcCtD
Ifosfamide—Alopecia—Pravastatin—atherosclerosis	0.000367	0.00209	CcSEcCtD
Ifosfamide—Cough—Ezetimibe—atherosclerosis	0.000366	0.00208	CcSEcCtD
Ifosfamide—Angioedema—Simvastatin—atherosclerosis	0.000365	0.00208	CcSEcCtD
Ifosfamide—Arthralgia—Lovastatin—atherosclerosis	0.000364	0.00207	CcSEcCtD
Ifosfamide—Chest pain—Lovastatin—atherosclerosis	0.000364	0.00207	CcSEcCtD
Ifosfamide—Myalgia—Lovastatin—atherosclerosis	0.000364	0.00207	CcSEcCtD
Ifosfamide—Hypertension—Ezetimibe—atherosclerosis	0.000362	0.00206	CcSEcCtD
Ifosfamide—Malaise—Simvastatin—atherosclerosis	0.00036	0.00205	CcSEcCtD
Ifosfamide—Discomfort—Lovastatin—atherosclerosis	0.000359	0.00205	CcSEcCtD
Ifosfamide—Vertigo—Simvastatin—atherosclerosis	0.000359	0.00204	CcSEcCtD
Ifosfamide—Leukopenia—Simvastatin—atherosclerosis	0.000358	0.00204	CcSEcCtD
Ifosfamide—Myalgia—Ezetimibe—atherosclerosis	0.000357	0.00203	CcSEcCtD
Ifosfamide—Chest pain—Ezetimibe—atherosclerosis	0.000357	0.00203	CcSEcCtD
Ifosfamide—Arthralgia—Ezetimibe—atherosclerosis	0.000357	0.00203	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000354	0.00202	CcSEcCtD
Ifosfamide—Discomfort—Ezetimibe—atherosclerosis	0.000352	0.00201	CcSEcCtD
Ifosfamide—Constipation—Rosuvastatin—atherosclerosis	0.000352	0.002	CcSEcCtD
Ifosfamide—Pain—Rosuvastatin—atherosclerosis	0.000352	0.002	CcSEcCtD
Ifosfamide—Confusional state—Lovastatin—atherosclerosis	0.000352	0.002	CcSEcCtD
Ifosfamide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000349	0.00198	CcSEcCtD
Ifosfamide—Infection—Lovastatin—atherosclerosis	0.000346	0.00197	CcSEcCtD
Ifosfamide—Vision blurred—Niacin—atherosclerosis	0.000346	0.00197	CcSEcCtD
Ifosfamide—Confusional state—Ezetimibe—atherosclerosis	0.000345	0.00196	CcSEcCtD
Ifosfamide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000342	0.00195	CcSEcCtD
Ifosfamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000341	0.00194	CcSEcCtD
Ifosfamide—Vision blurred—Pravastatin—atherosclerosis	0.00034	0.00194	CcSEcCtD
Ifosfamide—Myalgia—Simvastatin—atherosclerosis	0.00034	0.00194	CcSEcCtD
Ifosfamide—Chest pain—Simvastatin—atherosclerosis	0.00034	0.00194	CcSEcCtD
Ifosfamide—Arthralgia—Simvastatin—atherosclerosis	0.00034	0.00194	CcSEcCtD
Ifosfamide—Infection—Ezetimibe—atherosclerosis	0.00034	0.00193	CcSEcCtD
Ifosfamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000339	0.00193	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000336	0.00191	CcSEcCtD
Ifosfamide—Discomfort—Simvastatin—atherosclerosis	0.000336	0.00191	CcSEcCtD
Ifosfamide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000335	0.00191	CcSEcCtD
Ifosfamide—Angioedema—Niacin—atherosclerosis	0.000335	0.00191	CcSEcCtD
Ifosfamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000335	0.00191	CcSEcCtD
Ifosfamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000335	0.00191	CcSEcCtD
Ifosfamide—Anaemia—Pravastatin—atherosclerosis	0.000334	0.0019	CcSEcCtD
Ifosfamide—Anorexia—Lovastatin—atherosclerosis	0.000332	0.00189	CcSEcCtD
Ifosfamide—Skin disorder—Ezetimibe—atherosclerosis	0.000332	0.00189	CcSEcCtD
Ifosfamide—Angioedema—Pravastatin—atherosclerosis	0.00033	0.00188	CcSEcCtD
Ifosfamide—Vertigo—Niacin—atherosclerosis	0.00033	0.00188	CcSEcCtD
Ifosfamide—Confusional state—Simvastatin—atherosclerosis	0.000329	0.00187	CcSEcCtD
Ifosfamide—Leukopenia—Niacin—atherosclerosis	0.000328	0.00187	CcSEcCtD
Ifosfamide—Urticaria—Rosuvastatin—atherosclerosis	0.000327	0.00186	CcSEcCtD
Ifosfamide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000326	0.00186	CcSEcCtD
Ifosfamide—Oedema—Simvastatin—atherosclerosis	0.000326	0.00186	CcSEcCtD
Ifosfamide—Malaise—Pravastatin—atherosclerosis	0.000326	0.00185	CcSEcCtD
Ifosfamide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000325	0.00185	CcSEcCtD
Ifosfamide—Vertigo—Pravastatin—atherosclerosis	0.000325	0.00185	CcSEcCtD
Ifosfamide—Palpitations—Niacin—atherosclerosis	0.000324	0.00185	CcSEcCtD
Ifosfamide—Infection—Simvastatin—atherosclerosis	0.000324	0.00184	CcSEcCtD
Ifosfamide—Leukopenia—Pravastatin—atherosclerosis	0.000323	0.00184	CcSEcCtD
Ifosfamide—Cough—Niacin—atherosclerosis	0.00032	0.00182	CcSEcCtD
Ifosfamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000319	0.00182	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000318	0.00181	CcSEcCtD
Ifosfamide—Cough—Pravastatin—atherosclerosis	0.000315	0.00179	CcSEcCtD
Ifosfamide—Paraesthesia—Lovastatin—atherosclerosis	0.000313	0.00178	CcSEcCtD
Ifosfamide—Arthralgia—Niacin—atherosclerosis	0.000312	0.00178	CcSEcCtD
Ifosfamide—Myalgia—Niacin—atherosclerosis	0.000312	0.00178	CcSEcCtD
Ifosfamide—Hypertension—Pravastatin—atherosclerosis	0.000312	0.00178	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000312	0.00177	CcSEcCtD
Ifosfamide—Anorexia—Simvastatin—atherosclerosis	0.000311	0.00177	CcSEcCtD
Ifosfamide—Dyspnoea—Lovastatin—atherosclerosis	0.000311	0.00177	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00031	0.00177	CcSEcCtD
Ifosfamide—Arthralgia—Pravastatin—atherosclerosis	0.000308	0.00175	CcSEcCtD
Ifosfamide—Chest pain—Pravastatin—atherosclerosis	0.000308	0.00175	CcSEcCtD
Ifosfamide—Myalgia—Pravastatin—atherosclerosis	0.000308	0.00175	CcSEcCtD
Ifosfamide—Paraesthesia—Ezetimibe—atherosclerosis	0.000307	0.00175	CcSEcCtD
Ifosfamide—Dyspnoea—Ezetimibe—atherosclerosis	0.000305	0.00174	CcSEcCtD
Ifosfamide—Discomfort—Pravastatin—atherosclerosis	0.000304	0.00173	CcSEcCtD
Ifosfamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000303	0.00173	CcSEcCtD
Ifosfamide—Decreased appetite—Lovastatin—atherosclerosis	0.000303	0.00173	CcSEcCtD
Ifosfamide—Fatigue—Lovastatin—atherosclerosis	0.000301	0.00171	CcSEcCtD
Ifosfamide—Oedema—Niacin—atherosclerosis	0.000299	0.0017	CcSEcCtD
Ifosfamide—Anaphylactic shock—Niacin—atherosclerosis	0.000299	0.0017	CcSEcCtD
Ifosfamide—Pain—Lovastatin—atherosclerosis	0.000298	0.0017	CcSEcCtD
Ifosfamide—Constipation—Lovastatin—atherosclerosis	0.000298	0.0017	CcSEcCtD
Ifosfamide—Confusional state—Pravastatin—atherosclerosis	0.000297	0.00169	CcSEcCtD
Ifosfamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000297	0.00169	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000297	0.00169	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000295	0.00168	CcSEcCtD
Ifosfamide—Asthenia—Rosuvastatin—atherosclerosis	0.000295	0.00168	CcSEcCtD
Ifosfamide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000295	0.00168	CcSEcCtD
Ifosfamide—Oedema—Pravastatin—atherosclerosis	0.000295	0.00168	CcSEcCtD
Ifosfamide—Fatigue—Ezetimibe—atherosclerosis	0.000295	0.00168	CcSEcCtD
Ifosfamide—Infection—Pravastatin—atherosclerosis	0.000293	0.00167	CcSEcCtD
Ifosfamide—Paraesthesia—Simvastatin—atherosclerosis	0.000293	0.00167	CcSEcCtD
Ifosfamide—Pain—Ezetimibe—atherosclerosis	0.000292	0.00166	CcSEcCtD
Ifosfamide—Constipation—Ezetimibe—atherosclerosis	0.000292	0.00166	CcSEcCtD
Ifosfamide—Pruritus—Rosuvastatin—atherosclerosis	0.000291	0.00166	CcSEcCtD
Ifosfamide—Skin disorder—Niacin—atherosclerosis	0.000291	0.00166	CcSEcCtD
Ifosfamide—Dyspnoea—Simvastatin—atherosclerosis	0.000291	0.00165	CcSEcCtD
Ifosfamide—Hyperhidrosis—Niacin—atherosclerosis	0.000289	0.00165	CcSEcCtD
Ifosfamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000289	0.00164	CcSEcCtD
Ifosfamide—Feeling abnormal—Lovastatin—atherosclerosis	0.000287	0.00164	CcSEcCtD
Ifosfamide—Anorexia—Niacin—atherosclerosis	0.000285	0.00162	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000285	0.00162	CcSEcCtD
Ifosfamide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000285	0.00162	CcSEcCtD
Ifosfamide—Decreased appetite—Simvastatin—atherosclerosis	0.000283	0.00161	CcSEcCtD
Ifosfamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000282	0.0016	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000282	0.0016	CcSEcCtD
Ifosfamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Ifosfamide—Fatigue—Simvastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Ifosfamide—Anorexia—Pravastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Ifosfamide—Hypotension—Niacin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00028	0.00159	CcSEcCtD
Ifosfamide—Pain—Simvastatin—atherosclerosis	0.000279	0.00159	CcSEcCtD
Ifosfamide—Constipation—Simvastatin—atherosclerosis	0.000279	0.00159	CcSEcCtD
Ifosfamide—Urticaria—Lovastatin—atherosclerosis	0.000277	0.00158	CcSEcCtD
Ifosfamide—Body temperature increased—Lovastatin—atherosclerosis	0.000276	0.00157	CcSEcCtD
Ifosfamide—Abdominal pain—Lovastatin—atherosclerosis	0.000276	0.00157	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000273	0.00155	CcSEcCtD
Ifosfamide—Dizziness—Rosuvastatin—atherosclerosis	0.000272	0.00155	CcSEcCtD
Ifosfamide—Urticaria—Ezetimibe—atherosclerosis	0.000272	0.00155	CcSEcCtD
Ifosfamide—Body temperature increased—Ezetimibe—atherosclerosis	0.00027	0.00154	CcSEcCtD
Ifosfamide—Abdominal pain—Ezetimibe—atherosclerosis	0.00027	0.00154	CcSEcCtD
Ifosfamide—Paraesthesia—Niacin—atherosclerosis	0.000269	0.00153	CcSEcCtD
Ifosfamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000269	0.00153	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000269	0.00153	CcSEcCtD
Ifosfamide—Dyspnoea—Niacin—atherosclerosis	0.000267	0.00152	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000267	0.00152	CcSEcCtD
Ifosfamide—Somnolence—Niacin—atherosclerosis	0.000266	0.00152	CcSEcCtD
Ifosfamide—Paraesthesia—Pravastatin—atherosclerosis	0.000265	0.00151	CcSEcCtD
Ifosfamide—Dyspnoea—Pravastatin—atherosclerosis	0.000263	0.0015	CcSEcCtD
Ifosfamide—Decreased appetite—Niacin—atherosclerosis	0.00026	0.00148	CcSEcCtD
Ifosfamide—Rash—Rosuvastatin—atherosclerosis	0.000259	0.00148	CcSEcCtD
Ifosfamide—Dermatitis—Rosuvastatin—atherosclerosis	0.000259	0.00148	CcSEcCtD
Ifosfamide—Urticaria—Simvastatin—atherosclerosis	0.000259	0.00147	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000259	0.00147	CcSEcCtD
Ifosfamide—Abdominal pain—Simvastatin—atherosclerosis	0.000258	0.00147	CcSEcCtD
Ifosfamide—Body temperature increased—Simvastatin—atherosclerosis	0.000258	0.00147	CcSEcCtD
Ifosfamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000257	0.00146	CcSEcCtD
Ifosfamide—Decreased appetite—Pravastatin—atherosclerosis	0.000256	0.00146	CcSEcCtD
Ifosfamide—Pain—Niacin—atherosclerosis	0.000256	0.00146	CcSEcCtD
Ifosfamide—Fatigue—Pravastatin—atherosclerosis	0.000254	0.00145	CcSEcCtD
Ifosfamide—Pain—Pravastatin—atherosclerosis	0.000252	0.00144	CcSEcCtD
Ifosfamide—Constipation—Pravastatin—atherosclerosis	0.000252	0.00144	CcSEcCtD
Ifosfamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000252	0.00143	CcSEcCtD
Ifosfamide—Asthenia—Lovastatin—atherosclerosis	0.00025	0.00142	CcSEcCtD
Ifosfamide—Pruritus—Lovastatin—atherosclerosis	0.000247	0.0014	CcSEcCtD
Ifosfamide—Asthenia—Ezetimibe—atherosclerosis	0.000245	0.0014	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Niacin—atherosclerosis	0.000245	0.00139	CcSEcCtD
Ifosfamide—Nausea—Rosuvastatin—atherosclerosis	0.000244	0.00139	CcSEcCtD
Ifosfamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000243	0.00138	CcSEcCtD
Ifosfamide—Pruritus—Ezetimibe—atherosclerosis	0.000242	0.00138	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000241	0.00137	CcSEcCtD
Ifosfamide—Hypersensitivity—Simvastatin—atherosclerosis	0.00024	0.00137	CcSEcCtD
Ifosfamide—Diarrhoea—Lovastatin—atherosclerosis	0.000239	0.00136	CcSEcCtD
Ifosfamide—Urticaria—Niacin—atherosclerosis	0.000238	0.00135	CcSEcCtD
Ifosfamide—Abdominal pain—Niacin—atherosclerosis	0.000237	0.00135	CcSEcCtD
Ifosfamide—Body temperature increased—Niacin—atherosclerosis	0.000237	0.00135	CcSEcCtD
Ifosfamide—Urticaria—Pravastatin—atherosclerosis	0.000234	0.00133	CcSEcCtD
Ifosfamide—Asthenia—Simvastatin—atherosclerosis	0.000234	0.00133	CcSEcCtD
Ifosfamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000234	0.00133	CcSEcCtD
Ifosfamide—Body temperature increased—Pravastatin—atherosclerosis	0.000233	0.00133	CcSEcCtD
Ifosfamide—Abdominal pain—Pravastatin—atherosclerosis	0.000233	0.00133	CcSEcCtD
Ifosfamide—Pruritus—Simvastatin—atherosclerosis	0.000231	0.00131	CcSEcCtD
Ifosfamide—Dizziness—Lovastatin—atherosclerosis	0.000231	0.00131	CcSEcCtD
Ifosfamide—Dizziness—Ezetimibe—atherosclerosis	0.000226	0.00129	CcSEcCtD
Ifosfamide—Diarrhoea—Simvastatin—atherosclerosis	0.000223	0.00127	CcSEcCtD
Ifosfamide—Vomiting—Lovastatin—atherosclerosis	0.000222	0.00126	CcSEcCtD
Ifosfamide—Hypersensitivity—Niacin—atherosclerosis	0.000221	0.00126	CcSEcCtD
Ifosfamide—Rash—Lovastatin—atherosclerosis	0.00022	0.00125	CcSEcCtD
Ifosfamide—Dermatitis—Lovastatin—atherosclerosis	0.00022	0.00125	CcSEcCtD
Ifosfamide—Vomiting—Ezetimibe—atherosclerosis	0.000217	0.00124	CcSEcCtD
Ifosfamide—Hypersensitivity—Pravastatin—atherosclerosis	0.000217	0.00124	CcSEcCtD
Ifosfamide—Dizziness—Simvastatin—atherosclerosis	0.000216	0.00123	CcSEcCtD
Ifosfamide—Rash—Ezetimibe—atherosclerosis	0.000216	0.00123	CcSEcCtD
Ifosfamide—Dermatitis—Ezetimibe—atherosclerosis	0.000215	0.00123	CcSEcCtD
Ifosfamide—Asthenia—Niacin—atherosclerosis	0.000215	0.00122	CcSEcCtD
Ifosfamide—Pruritus—Niacin—atherosclerosis	0.000212	0.00121	CcSEcCtD
Ifosfamide—Asthenia—Pravastatin—atherosclerosis	0.000212	0.0012	CcSEcCtD
Ifosfamide—Pruritus—Pravastatin—atherosclerosis	0.000209	0.00119	CcSEcCtD
Ifosfamide—Vomiting—Simvastatin—atherosclerosis	0.000207	0.00118	CcSEcCtD
Ifosfamide—Nausea—Lovastatin—atherosclerosis	0.000207	0.00118	CcSEcCtD
Ifosfamide—Rash—Simvastatin—atherosclerosis	0.000206	0.00117	CcSEcCtD
Ifosfamide—Dermatitis—Simvastatin—atherosclerosis	0.000205	0.00117	CcSEcCtD
Ifosfamide—Diarrhoea—Niacin—atherosclerosis	0.000205	0.00117	CcSEcCtD
Ifosfamide—Nausea—Ezetimibe—atherosclerosis	0.000203	0.00116	CcSEcCtD
Ifosfamide—Diarrhoea—Pravastatin—atherosclerosis	0.000202	0.00115	CcSEcCtD
Ifosfamide—Dizziness—Niacin—atherosclerosis	0.000198	0.00113	CcSEcCtD
Ifosfamide—Dizziness—Pravastatin—atherosclerosis	0.000195	0.00111	CcSEcCtD
Ifosfamide—Nausea—Simvastatin—atherosclerosis	0.000194	0.0011	CcSEcCtD
Ifosfamide—Vomiting—Niacin—atherosclerosis	0.00019	0.00108	CcSEcCtD
Ifosfamide—Rash—Niacin—atherosclerosis	0.000189	0.00107	CcSEcCtD
Ifosfamide—Dermatitis—Niacin—atherosclerosis	0.000189	0.00107	CcSEcCtD
Ifosfamide—Vomiting—Pravastatin—atherosclerosis	0.000187	0.00107	CcSEcCtD
Ifosfamide—Rash—Pravastatin—atherosclerosis	0.000186	0.00106	CcSEcCtD
Ifosfamide—Dermatitis—Pravastatin—atherosclerosis	0.000186	0.00106	CcSEcCtD
Ifosfamide—Nausea—Niacin—atherosclerosis	0.000178	0.00101	CcSEcCtD
Ifosfamide—Nausea—Pravastatin—atherosclerosis	0.000175	0.000997	CcSEcCtD
Ifosfamide—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.39e-05	0.000189	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.39e-05	0.000188	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LPA—atherosclerosis	1.39e-05	0.000188	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOB—atherosclerosis	1.38e-05	0.000187	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.37e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.37e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.36e-05	0.000185	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.36e-05	0.000184	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.36e-05	0.000184	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.35e-05	0.000183	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LIPC—atherosclerosis	1.35e-05	0.000183	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOC3—atherosclerosis	1.34e-05	0.000182	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.34e-05	0.000182	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BGN—atherosclerosis	1.34e-05	0.000182	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOB—atherosclerosis	1.34e-05	0.000181	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LDLR—atherosclerosis	1.34e-05	0.000181	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.33e-05	0.000181	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.33e-05	0.00018	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.32e-05	0.000179	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—LPL—atherosclerosis	1.32e-05	0.000179	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CETP—atherosclerosis	1.31e-05	0.000177	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—atherosclerosis	1.3e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALB—atherosclerosis	1.3e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.29e-05	0.000175	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GPX1—atherosclerosis	1.29e-05	0.000174	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.28e-05	0.000173	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—LPL—atherosclerosis	1.28e-05	0.000173	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOB—atherosclerosis	1.27e-05	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.26e-05	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.25e-05	0.00017	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CD36—atherosclerosis	1.25e-05	0.00017	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.25e-05	0.00017	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.25e-05	0.000169	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.25e-05	0.000169	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GPX1—atherosclerosis	1.25e-05	0.000169	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NOS3—atherosclerosis	1.25e-05	0.000169	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.24e-05	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.24e-05	0.000167	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.23e-05	0.000167	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.22e-05	0.000165	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.22e-05	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.000165	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CD36—atherosclerosis	1.21e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—LPL—atherosclerosis	1.21e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.21e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.21e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.21e-05	0.000163	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.2e-05	0.000163	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.19e-05	0.000162	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.19e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.18e-05	0.00016	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GPX1—atherosclerosis	1.18e-05	0.00016	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CETP—atherosclerosis	1.17e-05	0.000158	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARA—atherosclerosis	1.16e-05	0.000158	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—MTHFR—atherosclerosis	1.15e-05	0.000156	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CD36—atherosclerosis	1.15e-05	0.000156	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.14e-05	0.000155	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—atherosclerosis	1.14e-05	0.000154	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.13e-05	0.000154	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.13e-05	0.000154	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARA—atherosclerosis	1.13e-05	0.000153	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AGT—atherosclerosis	1.13e-05	0.000153	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.12e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.11e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.11e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOE—atherosclerosis	1.11e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.1e-05	0.000149	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000149	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CAV1—atherosclerosis	1.1e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.09e-05	0.000148	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AGT—atherosclerosis	1.09e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOA1—atherosclerosis	1.09e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.09e-05	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.09e-05	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.09e-05	0.000147	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOE—atherosclerosis	1.07e-05	0.000145	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARA—atherosclerosis	1.07e-05	0.000145	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.07e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.06e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CETP—atherosclerosis	1.06e-05	0.000144	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CAV1—atherosclerosis	1.06e-05	0.000144	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOA1—atherosclerosis	1.06e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.05e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.05e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.04e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AGT—atherosclerosis	1.03e-05	0.00014	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOB—atherosclerosis	1.02e-05	0.000138	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.02e-05	0.000138	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOE—atherosclerosis	1.01e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.01e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CAV1—atherosclerosis	1e-05	0.000136	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOA1—atherosclerosis	1e-05	0.000136	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOB—atherosclerosis	9.98e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—atherosclerosis	9.98e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—atherosclerosis	9.94e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.91e-06	0.000134	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—LPL—atherosclerosis	9.75e-06	0.000132	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—atherosclerosis	9.71e-06	0.000132	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—atherosclerosis	9.67e-06	0.000131	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—atherosclerosis	9.63e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	9.61e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA2—atherosclerosis	9.58e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.58e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.58e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.58e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—LPL—atherosclerosis	9.53e-06	0.000129	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GPX1—atherosclerosis	9.52e-06	0.000129	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.5e-06	0.000129	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.47e-06	0.000128	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—INS—atherosclerosis	9.44e-06	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.39e-06	0.000127	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—atherosclerosis	9.33e-06	0.000126	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GPX1—atherosclerosis	9.3e-06	0.000126	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CD36—atherosclerosis	9.27e-06	0.000126	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—INS—atherosclerosis	9.15e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—atherosclerosis	9.14e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LPA—atherosclerosis	9.14e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CD36—atherosclerosis	9.06e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMOX1—atherosclerosis	9.03e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BGN—atherosclerosis	8.85e-06	0.00012	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—atherosclerosis	8.83e-06	0.00012	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.78e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA5—atherosclerosis	8.76e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.67e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—atherosclerosis	8.66e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—INS—atherosclerosis	8.66e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOB—atherosclerosis	8.65e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARA—atherosclerosis	8.62e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.58e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.56e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.44e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARA—atherosclerosis	8.42e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.41e-06	0.000114	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—atherosclerosis	8.39e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AGT—atherosclerosis	8.34e-06	0.000113	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NOS3—atherosclerosis	8.28e-06	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LPL—atherosclerosis	8.26e-06	0.000112	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOE—atherosclerosis	8.18e-06	0.000111	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AGT—atherosclerosis	8.16e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.15e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAV1—atherosclerosis	8.1e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOA1—atherosclerosis	8.08e-06	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.06e-06	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GPX1—atherosclerosis	8.06e-06	0.000109	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NOS3—atherosclerosis	8.03e-06	0.000109	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOE—atherosclerosis	7.99e-06	0.000108	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—atherosclerosis	7.94e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAV1—atherosclerosis	7.92e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOA1—atherosclerosis	7.9e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CD36—atherosclerosis	7.85e-06	0.000106	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOB—atherosclerosis	7.72e-06	0.000105	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NOS3—atherosclerosis	7.59e-06	0.000103	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—atherosclerosis	7.57e-06	0.000103	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.51e-06	0.000102	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.43e-06	0.000101	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.38e-06	9.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LPL—atherosclerosis	7.37e-06	9.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.35e-06	9.95e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—atherosclerosis	7.34e-06	9.94e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.31e-06	9.9e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARA—atherosclerosis	7.29e-06	9.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LIPC—atherosclerosis	7.26e-06	9.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOC3—atherosclerosis	7.22e-06	9.78e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.21e-06	9.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GPX1—atherosclerosis	7.19e-06	9.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LDLR—atherosclerosis	7.17e-06	9.72e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—atherosclerosis	7.12e-06	9.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AGT—atherosclerosis	7.06e-06	9.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOB—atherosclerosis	7.04e-06	9.53e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CETP—atherosclerosis	7.01e-06	9.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CD36—atherosclerosis	7e-06	9.48e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—INS—atherosclerosis	6.98e-06	9.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—atherosclerosis	6.96e-06	9.43e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—atherosclerosis	6.94e-06	9.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOE—atherosclerosis	6.92e-06	9.37e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAV1—atherosclerosis	6.86e-06	9.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.85e-06	9.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOA1—atherosclerosis	6.84e-06	9.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—INS—atherosclerosis	6.83e-06	9.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LPL—atherosclerosis	6.72e-06	9.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.71e-06	9.09e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.64e-06	8.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GPX1—atherosclerosis	6.56e-06	8.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARA—atherosclerosis	6.51e-06	8.82e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—atherosclerosis	6.4e-06	8.67e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CD36—atherosclerosis	6.39e-06	8.65e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.34e-06	8.58e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AGT—atherosclerosis	6.3e-06	8.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—atherosclerosis	6.26e-06	8.48e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.25e-06	8.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOE—atherosclerosis	6.18e-06	8.37e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NOS3—atherosclerosis	6.12e-06	8.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAV1—atherosclerosis	6.12e-06	8.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOA1—atherosclerosis	6.11e-06	8.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.05e-06	8.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—atherosclerosis	6.03e-06	8.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NOS3—atherosclerosis	5.99e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARA—atherosclerosis	5.94e-06	8.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—INS—atherosclerosis	5.91e-06	8.01e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AGT—atherosclerosis	5.75e-06	7.79e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—atherosclerosis	5.73e-06	7.76e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.65e-06	7.65e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOE—atherosclerosis	5.63e-06	7.63e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.6e-06	7.59e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAV1—atherosclerosis	5.58e-06	7.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.58e-06	7.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOA1—atherosclerosis	5.57e-06	7.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.48e-06	7.42e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—atherosclerosis	5.42e-06	7.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—atherosclerosis	5.38e-06	7.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—INS—atherosclerosis	5.28e-06	7.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NOS3—atherosclerosis	5.19e-06	7.02e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.08e-06	6.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—atherosclerosis	4.91e-06	6.64e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.85e-06	6.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—atherosclerosis	4.84e-06	6.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—INS—atherosclerosis	4.81e-06	6.52e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.74e-06	6.42e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOB—atherosclerosis	4.64e-06	6.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NOS3—atherosclerosis	4.63e-06	6.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.52e-06	6.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LPL—atherosclerosis	4.43e-06	6e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—atherosclerosis	4.41e-06	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GPX1—atherosclerosis	4.32e-06	5.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.23e-06	5.73e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NOS3—atherosclerosis	4.22e-06	5.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CD36—atherosclerosis	4.21e-06	5.7e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.99e-06	5.4e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARA—atherosclerosis	3.91e-06	5.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.86e-06	5.23e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—atherosclerosis	3.81e-06	5.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AGT—atherosclerosis	3.79e-06	5.13e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOE—atherosclerosis	3.71e-06	5.03e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—atherosclerosis	3.69e-06	5e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAV1—atherosclerosis	3.68e-06	4.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA1—atherosclerosis	3.67e-06	4.97e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—atherosclerosis	3.49e-06	4.73e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.35e-06	4.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—atherosclerosis	3.24e-06	4.38e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—INS—atherosclerosis	3.17e-06	4.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—atherosclerosis	2.91e-06	3.94e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—atherosclerosis	2.82e-06	3.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NOS3—atherosclerosis	2.78e-06	3.77e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—atherosclerosis	2.75e-06	3.73e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.55e-06	3.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—atherosclerosis	2.38e-06	3.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—atherosclerosis	2.13e-06	2.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—atherosclerosis	1.94e-06	2.63e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.28e-06	1.73e-05	CbGpPWpGaD
